New study: Fecal microbiota transplantation does not help with irritable bowel syndrome
A new study shows that treatment with donor stool has no effect on patients with irritable bowel syndrome (IBS). Many had hoped that the introduction of healthy gut bacteria from healthy donors could alleviate symptoms, but the research results are clear.
In the study, one group of patients received treatment with donor stool, while a control group received a form of placebo treatment. The researchers found no significant difference in improvement between the two groups. This means that the method does not work better than a placebo for this patient group.
Irritable bowel syndrome is a common condition that affects the daily lives of many Norwegians. Because there are few effective treatments available today, there has been great interest in seeing whether changes to the gut flora could be the key to better health. This study is therefore an important contribution to understanding what actually works.
The researchers behind the study conclude that fecal transplantation should not be offered as a standard treatment for IBS. They emphasize that it is important to base medical advice on thorough research to avoid unnecessary interventions.
The results mean that patients with IBS must continue to look for other treatment methods in consultation with their doctor. Research in the field continues, but for the time being, donor stool is not the solution for this diagnosis.